As of 9:30 AM on the 26th, Access Bio is trading at 29,100 KRW, down 3.64% from the previous day. This represents a 446.99% increase compared to July 28. Access Bio is known as a specialized manufacturer of in vitro diagnostic products such as malaria diagnostic kits.

Over the past five days, individual investors have net purchased 1,101,403 shares, while foreigners and institutions have net sold 82,297 shares and 652,854 shares, respectively.


On August 24, Access Bio became a market issue with the headline "Two consecutive trading days of sharp decline... from the 60,000 KRW range down to the 20,000 KRW range."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing